The Longevity Biotech Show
#020: Daniel Oliver (Rejuvenate Bio) - July 21, 2021

#020: Daniel Oliver (Rejuvenate Bio) - July 21, 2021

July 21, 2021

Daniel Oliver is the CEO and co-founder of Rejuvenate Bio, a George Church lab spinout that is developing gene therapies to reverse aging in dogs. 

#019: Future of Longevity II (George Church, Nir Barzilai, Kristen Fortney, Jim Mellon, Alejandro Ocampo, Jay Olshansky) - July 14th, 2021

#019: Future of Longevity II (George Church, Nir Barzilai, Kristen Fortney, Jim Mellon, Alejandro Ocampo, Jay Olshansky) - July 14th, 2021

July 14, 2021

Our second monthly Future of Longevity panel discussion featuring:

  • George Church (Harvard Medical School)
  • Nir Barzilai (Albert Einstein College of Medicine)
  • Kristen Fortney (BioAge Labs)
  • Jim Mellon (Juvenescence)
  • Jay Olshansky (University of Illinois at Chicago)
  • Alejandro Ocampo (University of Lausanne)
#018: Anil Bhushan (Deciduous Therapeutics) - July 1st, 2021

#018: Anil Bhushan (Deciduous Therapeutics) - July 1st, 2021

July 1, 2021

Anil Bhushan is a professor at the University of California San Francisco and also a co-founder of Deciduous Therapeutics, a longevity biotech company developing an immunotherapy to remove senescent cells. 

#017: Longevity Panel: The scientists working on reversing aging - June 15th, 2021

#017: Longevity Panel: The scientists working on reversing aging - June 15th, 2021

June 16, 2021

A panel talk with scientists and thought leaders in age reversal and longevity science. Featuring:

  • Aubrey de Grey (Founder of SENS Research Foundation, author of "Ending Aging") 
  • David Sinclair (Harvard Medical School, Life Biosciences, author of "Lifespan: Why We Age -- and Why We Don't Have to")
  • Joao Pedro de Magalhaes (University of Liverpool, CSO at Centaura)
  • Liz Parrish (Founder of Bioviva Science)
  • Jean Hebert (Albert Einstein College of Medicine, author of "Replacing Aging")
  • Alexandra Stolzing (SENS Research Foundation, Loughborough University)
  • Greg Fahy (Intervene Immune)
  • David Gobel (Methuselah Foundation, Methuselah Fund)

Hosted by: Laura Minquini (MYKIGAI, Let's Talk Longevity), Avi Roy (Oxford University), and Nathan Cheng (Longevity Marketcap / Longevity List)

 

#016: Sebastian Brunemeier (ex Apollo Health Ventures, co-founder Cambrian Biopharma) - June 10th, 2021

#016: Sebastian Brunemeier (ex Apollo Health Ventures, co-founder Cambrian Biopharma) - June 10th, 2021

June 10, 2021

Sebastian Brunemeier is a geroscientist, biotech founder, and venture capitalist. He was formerly Principal at Apollo Health Ventures, one of the largest aging-focussed VC firms in the world. Sebastian was co-founder of Samsara Therapeutics, Cyclone Therapeutics, Cambrian Biopharma, and advisor to several other biotech startups and Healthspan Capital.

#015: Marinna Madrid (Cellino) - June 3rd, 2021

#015: Marinna Madrid (Cellino) - June 3rd, 2021

June 3, 2021

Marinna Madrid is a co-founder of Cellino, a startup that leverages AI, robotics, and laser-editing to develop and manufacture stem cell therapies at scale. She obtained her Ph.D in Physics from Harvard and was named a Forbes Top 30 under 30 in healthcare.

#014: Tyler Golato (VitaDAO) - May 27th, 2021

#014: Tyler Golato (VitaDAO) - May 27th, 2021

May 27, 2021

Tyler Golato is one of the masterminds behind VitaDAO, a decentralized organization that aims to fund and commercialize longevity research -- all on the Ethereum blockchain. 

#013: Marco Quarta (Rubedo Life Sciences) - May 20th, 2021

#013: Marco Quarta (Rubedo Life Sciences) - May 20th, 2021

May 20, 2021

Marco Quarta is a co-founder and CEO of Rubedo Life Science, a company developing targeted therapies to extend healthspan. Rubedo has built a drug discovery platform with an initial focus on prodrugs that remove senescent cells in a highly selective manner.

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

May 6, 2021

Matthew Scholz is the co-founder of Oisin Biotechnologies, a gene therapy platform company that is targeting aging by killing senescent cells. We discuss the technology behind Oisin, Matt's journey from computer science to biotech, and practical advice and wisdom he gained from building biotech startups.

#011: Kristen Fortney (BioAge Labs) - April 29th, 2021

#011: Kristen Fortney (BioAge Labs) - April 29th, 2021

April 29, 2021

Kristen Fortney is the CEO and co-founder of BioAge Labs, an a16z-backed  startup that leverages artificial intelligence and machine learning to discover anti-aging drugs. 

Podbean App

Play this podcast on Podbean App